Tag: cancer tumor profiling industry

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theCancer Tumor Profiling Market from 2025 to 2034?

The rise in cancer cases worldwide is anticipated to fuel the expansion of the cancer and tumor profiling market. This surge is attributed to the uncontrollable growth and spread of certain body cells, a crucial character of cancer. Consequently, the rise in cancer instances is directly proportional to the need for cancer tumor profiling, as it allows medical practitioners to establish the disease’s severity. For example, the American Cancer Society, a U.S.-based professional body, recorded an increase from 1.9 million new cancer cases in 2023 to 2 million in 2024. Therefore, the escalating occurrence of cancer globally instigates the development of the cancer and tumor profiling market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6053&type=smp

#What Growth Opportunities Will Drive the Cancer Tumor Profiling Market’s CAGR Through 2034?

In recent times, there has been a swift expansion in the market size of cancer tumor profiling. It is projected to surge from $13 billion in 2024 to $14.99 billion in 2025, representing a compound annual growth rate (CAGR) of 15.3%. The notable growth during the historical period can be credited to factors such as the rising number of cancer cases, advancements in precision medicine activities and research partnerships, enhanced cancer diagnostic procedures and methods of early detection, the provision of a broad array of targeted treatment options, and favorable regulatory structures for cancer profiling tests.

In the coming years, the cancer tumor profiling market is predicted to experience significant expansion, escalating to a worth of $25.33 billion in 2029, with a compound annual growth rate (CAGR) of 14.0%. The projected growth during this period can be linked to the broadening of immunotherapy and immunoprofiling usage in cancer treatment, advancements in liquid biopsy and non-invasive tumor profiling techniques, increasing adoption of single-cell sequencing for comprehensive tumor analysis, enlargement of cancer screening and early detection initiatives, and growing demand for profiling of unusual and orphan cancer subtypes. Key market trends anticipated during this period include the incorporation of tumor profiling into standard clinical procedures, progress in multi-omics methodologies, the integration of artificial intelligence (AI) and machine learning in data analytics, the evolution of personalized medicine and targeted therapies, and the advancement in genomic and next-generation sequencing (NGS) technologies.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6053

How Are Market Trends and Innovations Revolutionizing theCancer Tumor Profiling Industry in Recent Times?

The surge in research and development undertakings is becoming a prevalent trend in the cancer and tumor profiling market. Esteemed companies in this sector are channeling their efforts into research and development activities to cater to customer needs and consolidate their market standing. For instance, QIAGEN N.V, a company based in Germany known for its sample and assay technology in applied testing, pharmaceutical development, molecular diagnostics, and academic research, publicized the CE-marking and commercial launch of the therascreen PIK3CA RGQ PCR Kit in Europe. This kit is a tool aimed at identifying breast cancer patients with mutations in the PIK3CA gene. The therascreen PIK3CA test is a diagnostic assay designed for detecting an activating mutation in the PIK3CA gene and it is the first of its kind that allows the testing of DNA derived from plasma samples or FFPE tissue.

Which Key Market Players Are Shaping the Future and Growth of theCancer Tumor Profiling Market?

Major companies operating in the cancer tumor profiling market include F. Hoffmann-La Roche Ltd., Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., Qiagen, Ribomed Biotechnologies Inc., HTG Molecular Diagnostics Inc., NanoString Technologies Inc., NeoGenomics Laboratories Inc., Lucence Health Inc., ACT Genomics Co. LTD, Strand Life Sciences, IMB Dx Inc., Exact Sciences Corporation, Guardant Health, Foundation Medicine Inc., Agilent Technologies Inc., Myriad Genetics Inc., Personal Genome Diagnostics Inc., Tempus Labs Inc., ArcherDX Inc., Natera Inc., Bio-Rad Laboratories Inc., Genetron Health, NantHealth Inc., Resolution Bioscience, Genomic Testing Cooperative, OncoDNA, Strata Oncology Inc., Genuity Science, RareCyte Inc., Inivata Limited, Cepheid

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

What Are the Core Segments of the Cancer Tumor Profiling Market, and How Do They Contribute to Growth?

The cancer tumor profiling market covered in this report is segmented –

1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies

3) By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Other Types

4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications

Subsegments:

1) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)

2) By Breast Cancer: Hormone Receptor-Positive, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer

3) By Colorectal Cancer: Colon Cancer, Rectal Cancer

4) By Prostate Cancer: Localized Prostate Cancer, Advanced Prostate Cancer

5) By Melanoma: Cutaneous Melanoma, Non-Cutaneous Melanoma

6) By Ovarian Cancer: Epithelial Ovarian Cancer, Non-Epithelial Ovarian Cancer

7) By Stomach Cancer: Gastric Adenocarcinoma, Gastrointestinal Stromal Tumors (GISTs)

8) By Pancreatic Cancer: Exocrine Pancreatic Cancer, Neuroendocrine Tumors

9) By Thyroid Cancer: Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer

10) By Other Cancer Types: Kidney Cancer, Bladder Cancer, Liver Cancer, Esophageal Cancer

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=6053&type=smp

What Regions Are Dominating the Cancer Tumor Profiling Market Growth?

North America was the largest region in cancer and tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer tumor profiling market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Gobal Cancer Tumor Profiling Maret 2025, By The Business Research Company:

Cancer Clinical Decision Tools Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-clinical-decision-tool-global-market-report

Tumor Ablation Therapy Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the cancer tumor profiling market grown over the years?

The market size for cancer tumor profiling has seen a quick expansion in the last few years. It is projected to increase from $13 billion in 2024 to $14.99 billion in 2025, with a compound annual growth rate (CAGR) of 15.3%. The noteworthy growth in the past period is tied to factors such as the rise in the cases of cancer, expansion in precision medicine initiatives and research partnerships, enhancements in cancer diagnosis and methods for early detection, the availability of numerous targeted therapy alternatives, and positive governmental regulations pertaining to cancer profiling tests.

What Is the forecasted market size and growth rate for the cancer tumor profiling market?

In the coming years, the market size for cancer tumor profiling is projected to experience significant growth, reaching $25.33 billion by 2029 with a compound annual growth rate (CAGR) of 14.0%. This growth within the anticipated period is largely due to the expansion of immunotherapy and immunoprofiling in the treatment of cancer, advancements in liquid biopsy and non-invasive profiling of tumors, the usage of single-cell sequencing for more intricate tumor characterization, broadening of cancer screening and early detection programs, and a higher demand for rare and orphan cancer subtype profiling. Key trends over the forecast period consist of incorporating tumor profiling into regular clinical practice, progress in multi-omics approaches, the incorporation of artificial intelligence (AI) and machine learning for data analysis, personalized medicine and development of targeted treatments, and advances in the field of genomics and next-generation sequencing (NGS) technologies.

Get your cancer tumor profiling market report here!

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

What are the major factors driving growth in the cancer tumor profiling market?

In the coming years, the market size for cancer tumor profiling is projected to experience significant growth, reaching $25.33 billion by 2029 with a compound annual growth rate (CAGR) of 14.0%. This growth within the anticipated period is largely due to the expansion of immunotherapy and immunoprofiling in the treatment of cancer, advancements in liquid biopsy and non-invasive profiling of tumors, the usage of single-cell sequencing for more intricate tumor characterization, broadening of cancer screening and early detection programs, and a higher demand for rare and orphan cancer subtype profiling. Key trends over the forecast period consist of incorporating tumor profiling into regular clinical practice, progress in multi-omics approaches, the incorporation of artificial intelligence (AI) and machine learning for data analysis, personalized medicine and development of targeted treatments, and advances in the field of genomics and next-generation sequencing (NGS) technologies.

What key areas define the segmentation of the global cancer tumor profiling Market?

The cancer tumor profiling market covered in this report is segmented –

1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies

3) By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Other Types

4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications

Subsegments:

1) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)

2) By Breast Cancer: Hormone Receptor-Positive, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer

3) By Colorectal Cancer: Colon Cancer, Rectal Cancer

4) By Prostate Cancer: Localized Prostate Cancer, Advanced Prostate Cancer

5) By Melanoma: Cutaneous Melanoma, Non-Cutaneous Melanoma

6) By Ovarian Cancer: Epithelial Ovarian Cancer, Non-Epithelial Ovarian Cancer

7) By Stomach Cancer: Gastric Adenocarcinoma, Gastrointestinal Stromal Tumors (GISTs)

8) By Pancreatic Cancer: Exocrine Pancreatic Cancer, Neuroendocrine Tumors

9) By Thyroid Cancer: Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer

10) By Other Cancer Types: Kidney Cancer, Bladder Cancer, Liver Cancer, Esophageal Cancer

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6053&type=smp

What are the top market players propelling the growth of the cancer tumor profiling industry?

Major companies operating in the cancer tumor profiling market include F. Hoffmann-La Roche Ltd., Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., Qiagen, Ribomed Biotechnologies Inc., HTG Molecular Diagnostics Inc., NanoString Technologies Inc., NeoGenomics Laboratories Inc., Lucence Health Inc., ACT Genomics Co. LTD, Strand Life Sciences, IMB Dx Inc., Exact Sciences Corporation, Guardant Health, Foundation Medicine Inc., Agilent Technologies Inc., Myriad Genetics Inc., Personal Genome Diagnostics Inc., Tempus Labs Inc., ArcherDX Inc., Natera Inc., Bio-Rad Laboratories Inc., Genetron Health, NantHealth Inc., Resolution Bioscience, Genomic Testing Cooperative, OncoDNA, Strata Oncology Inc., Genuity Science, RareCyte Inc., Inivata Limited, Cepheid

What are the key trends shaping the future of the cancer tumor profiling market?

A significant emerging trend in the cancer and tumor profiling market is the escalating focus on research and development activities. This trend is particularly popular among major firms in the sector, who are concentrating their efforts on these activities as a means of satisfying customer needs and strengthening their market position. A case in point is QIAGEN N.V., a German business specializing in the development of sample and assay technology for a range of uses, including applied testing, pharmaceutical development, molecular diagnostics, and academic research. To further underline this emerging trend, QIAGEN N.V. recently announced the CE-marking and subsequent commercialization of their therascreen PIK3CA RGQ PCR Kit in Europe. This tool seeks to aid in the identification of breast cancer patients with PIK3CA mutations. The therascreen PIK3CA test, not only detects an activating mutation in the phosphatidyl 3-kinase catalytic subunit alpha (PIK3CA) gene, but it is also the first of its kind to permit the testing of both DNA from plasma specimens or FFPE tissue.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6053

What regions are dominating the cancer tumor profiling market growth?

North America was the largest region in cancer and tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer tumor profiling market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Cancer Clinical Decision Tools Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-clinical-decision-tool-global-market-report

Tumor Ablation Therapy Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Cancer Tumor Profiling Market Over the Coming Decade?

In recent years, the cancer tumor profiling market size has seen a substantial increase. It is anticipated to escalate from $13 billion in 2024 to $14.99 billion in 2025, marking a compound annual growth rate (CAGR) of 15.3%. Factors contributing to this growth during the historical period include a rise in cancer cases, advancements in precision medicine initiatives and collaborative research, enhanced methods for early detection and diagnostics of cancer, a broad spectrum of targeted therapy options, and favorable regulations pertaining to cancer profiling tests.

In the upcoming years, the market size for cancer tumor profiling is set to experience significant expansion, reaching $25.33 billion in 2029 with a 14.0% compound annual growth rate (CAGR). The anticipated growth during the projection period is due to factors such as the adoption and expansion of cancer treatment techniques such as immunotherapy, immunoprofiling, liquid biopsy, and non-invasive tumor profiling methods. The upsurge in the use of single-cell sequencing for thorough tumor characterization, the growth of early cancer detection and screening programs, and the growing need for profiling of rare and orphan cancer subtypes also contribute to this market expansion. The forecast period will witness several emerging trends like the incorporation of tumor profiling into regular clinical practices, advancements in multi-omics approaches, the use of artificial intelligence (AI) and machine learning for data analysis, development of personalized medicine and targeted therapies, and progress in genomics and next-generation sequencing (NGS) technologies.

Which Factors Are Enhancing the Growth of the cancer tumor profiling Market?

The global rise in cancer cases is anticipated to drive the expansion of the cancer and tumor profiling market. Cancer, a disease characterized by the unregulated growth and spread of certain cells in the body, is becoming more prevalent. This surge in cancer cases prompts an increased need for cancer tumor profiling, a tool that helps physicians assess the disease’s severity. For example, the American Cancer Society, a professional organization based in the U.S., reported an increase in new cancer cases from 1.9 million in 2023 to 2 million in 2024. Consequently, this global increase in cancer cases fuels the growth of the cancer and tumor profiling market.

Explore Comprehensive Insights Into The Global Cancer Tumor Profiling Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6053&type=smp

What Are the Major Players Making an Impact in the Cancer Tumor Profiling Market’s Growth?

Major companies operating in the cancer tumor profiling market include:

• F. Hoffmann-La Roche Ltd._x000D_

• Caris Life Sciences_x000D_

• Thermo Fisher Scientific Inc._x000D_

• Illumina Inc._x000D_

• Qiagen_x000D_

Which Upcoming Trends Are Set to Influence the Cancer Tumor Profiling Market’s Path Forward?

Rising research and development endeavors are becoming a prominent trend in the cancer and tumor profiling market. Major corporations in this sector are targeting these activities to cater to customer demands and strengthen their standing. Take for example, QIAGEN N.V, a German firm specializing in sample and assay technology for applied testing, pharmaceutical development, molecular diagnostics, and academic study; it recently announced the authentication and sales launch of its therascreen PIK3CA RGQ PCR Kit in Europe. This tool is of essence in identifying breast cancer patients who have PIK3CA mutations. The therascreen PIK3CA test is a diagnostic assay used to detect an activating mutation in the PIK3CA gene and is the first of its kind that allows both plasma specimens and FFPE tissue DNA testing.

Secure Your Global Cancer Tumor Profiling Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Which Key Segments of the Cancer Tumor Profiling Market Are Poised for Growth and Innovation?

The cancer tumor profiling market covered in this report is segmented –

1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies

3) By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Other Types

4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications

Subsegments:

1) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)

2) By Breast Cancer: Hormone Receptor-Positive, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer

3) By Colorectal Cancer: Colon Cancer, Rectal Cancer

4) By Prostate Cancer: Localized Prostate Cancer, Advanced Prostate Cancer

5) By Melanoma: Cutaneous Melanoma, Non-Cutaneous Melanoma

6) By Ovarian Cancer: Epithelial Ovarian Cancer, Non-Epithelial Ovarian Cancer

7) By Stomach Cancer: Gastric Adenocarcinoma, Gastrointestinal Stromal Tumors (GISTs)

8) By Pancreatic Cancer: Exocrine Pancreatic Cancer, Neuroendocrine Tumors

9) By Thyroid Cancer: Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer

10) By Other Cancer Types: Kidney Cancer, Bladder Cancer, Liver Cancer, Esophageal Cancer

What Regions Are Steering Growth in the Cancer Tumor Profiling Sector?

North America was the largest region in cancer and tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer tumor profiling market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Is the Cancer Tumor Profiling Market Classified and Defined in Market Analysis?

Cancer tumor profiling refers to a laboratory test that examines a sample of tumor tissue for specific genes, gene mutations (changes), proteins, or other biomarkers. Tumor profiling can help with treatment planning as well as predicting if cancer will recur or spread to other parts of the body.

Browse Through More Similar Reports By The Business Research Company:

Cancer Clinical Decision Tools Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-clinical-decision-tool-global-market-report

Tumor Ablation Therapy Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: